Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
5 pending office actions • 5 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Ocusoft Inc. has 5 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 5 distinct examiners and 5 distinct art units, with each active matter occupying a separate examination assignment.
THOMAE, EVAN GODFREY is the busiest examiner, with 1 pending matter. The available data supports a matter-specific prosecution strategy rather than centralized examiner management.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (20%) |
| §103 only | 3 (60%) |
| Multi-statute (no §101) | 1 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| THOMAE, EVAN GODFREY | 1 | — | — |
| SPAINE, ROBERT FRANKLIN | 1 | 75.0% | +0.0% |
| KWON, YONG SOK | 1 | 24.6% | +42.7% |
| YU, HONG | 1 | 31.1% | +5.7% |
| EKRAMI, YASAMIN | 1 | 41.6% | +46.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17861588 | SKIN MOISTURIZING COMPOSITIONS | YU, HONG | 16d overdue |
| 18617328 | HYPOCHLOROUS ACID-BASED DRY EYE FORMULATIONS | KWON, YONG SOK | 16d |
| 18639128 | ANTI-ALLERGENIC OCULAR COMPOSITIONS | SPAINE, ROBERT FRANKLIN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18617328 | HYPOCHLOROUS ACID-BASED DRY EYE FORMULATIONS | KWON, YONG SOK | 16d |
| 16683660 | EYE MASK | EKRAMI, YASAMIN | — |
| Art Unit | Apps |
|---|---|
| 1623 | 1 |
| 1655 | 1 |
| 1613 | 1 |
| 1614 | 1 |
| 3794 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19069015 | TOPICAL FORMULATIONS FOR THERAPEUTICALLY ACTIVE AGENTS | THOMAE, EVAN GODFREY | 1623 | §103 | Non-Final OA | — | Pending | Mar 03, 2025 |
| 18639128 | ANTI-ALLERGENIC OCULAR COMPOSITIONS | SPAINE, ROBERT FRANKLIN | 1655 | §101§103§112 | Non-Final OA | — | Pending | Apr 18, 2024 |
| 18617328 | HYPOCHLOROUS ACID-BASED DRY EYE FORMULATIONS | KWON, YONG SOK | 1613 | §103 | Final Rejection | 16d | Pending | Mar 26, 2024 |
| 17861588 | SKIN MOISTURIZING COMPOSITIONS | YU, HONG | 1614 | §102§103 | Non-Final OA | 16d overdue | Pending | Jul 11, 2022 |
| 16683660 | EYE MASK | EKRAMI, YASAMIN | 3794 | §103 | Non-Final OA | — | Pending | Nov 14, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialOcusoft Inc. has 5 pending office actions as of October 2026, spread across 5 art units and 5 examiners.
Evan Godfrey Thomae has the most, with 1 of Ocusoft Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
